[1]
A. Armstrong, M. Lebwohl, L. Stein Gold, and A. Jacobson, “Brodalumab Provides Rapid Onset of Therapeutic Response for Patients With Moderate-to-Severe Psoriasis”, J of Skin, vol. 7, no. 2, p. s133, Mar. 2023.